Respiratory Tract Infections Management

Diagnosis and Assessment

• The American College of Physicians recommends distinguishing between acute bronchitis and pneumonia by checking for tachycardia, tachypnea, fever, and abnormal chest examination findings, as pneumonia is unlikely in immunocompetent adults <70 years without these signs 1
• Colored sputum does not indicate bacterial infection, but rather is due to inflammatory cells, according to the American College of Physicians 1

Treatment

• The American College of Physicians suggests symptomatic relief options, including cough suppressants, expectorants, first-generation antihistamines, decongestants, and β-agonists, which are only beneficial in patients with underlying asthma or COPD 1, 2
• For patients with established chronic bronchitis, the American College of Chest Physicians recommends against overusing antibiotics for viral bronchitis, as more than 70% of acute bronchitis visits result in antibiotic prescriptions despite limited evidence of benefit 1, 2

Antibiotic Use

• The European Respiratory Society recommends first-line antibiotic treatment with Amoxicillin (3g/day) for 7-10 days for exacerbation of chronic bronchitis meeting Anthonisen criteria 3
• The Anthonisen criteria for determining the need for antibiotic therapy in exacerbations of chronic bronchitis include at least 2 of 3 criteria:

4

• First-line antibiotic options include amoxicillin, first-generation cephalosporins, and macrolides or doxycycline for beta-lactam allergies, as recommended by the American Thoracic Society and the American College of Chest Physicians 3
• The American Academy of Family Physicians recommends against routine antibiotic treatment for acute uncomplicated bronchitis, as it does not consistently impact the duration or severity of illness, prevention of complications, or activity limitation 5

Treatment Duration and Monitoring

• The Infectious Diseases Society of America recommends a treatment duration of 7-10 days for bacterial sinusitis, acute otitis media, and exacerbations of chronic bronchitis 3
• The European Respiratory Society recommends treatment duration of 7-10 days for uncomplicated community-acquired pneumonia cases and 21 days for L. pneumophila or S. aureus infections 6, 7
• Patients should return if symptoms persist beyond 3 weeks and seek immediate attention if warning signs such as fever exceeding 4 days, worsening dyspnea, decreased fluid intake, or altered consciousness occur, as advised by the Clinical Microbiology and Infection journal 8

Patient Education and Antibiotic Stewardship

• Patients should be informed that bronchitis is typically viral and self-limiting, and that cough typically lasts 2-3 weeks regardless of treatment, and the importance of returning if symptoms worsen or fever persists >3 days should be emphasized, as recommended by the American Academy of Family Physicians 3, 5
• When antibiotics are not indicated, explain to patients that the illness is likely viral and self-limiting, with an expected duration of cough, and discuss the risks of unnecessary antibiotic use, including increased likelihood of antibiotic-resistant infections, common side effects, and rare but serious adverse reactions 5
• The Clinical Microbiology and Infection journal recommends considering local resistance patterns when selecting antibiotics, and notes an increasing incidence of resistant Staphylococcus, Haemophilus, and Streptococcus infections 8, 7